Publications by authors named "Edoardo Scomazzon"

Claim this Profile
H
Hip resection arthroplasty as a primary treatment of displaced neck fracture in non-ambulatory and fragile patients.
Dario Regis, Elisa Sartore, Edoardo Scomazzon, Romolo Borgese, Bruno Magnan

World J Orthop· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lenalidomide maintenance after bortezomib, thalidomide and dexamethasone (VTD) induction and autologous stem cell transplantation: an Italian real-life study of 602 patients.
Gregorio Barilà, Angela Grassi, Concetta Conticello, Roberto Mina, Chiara Marcon, Edoardo Scomazzon

Haematologica· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HSP70/HSF1 axis, regulated via a PI3K/AKT pathway, is a druggable target in chronic lymphocytic leukemia.
Federica Frezzato, Flavia Raggi, Veronica Martini, Filippo Severin, Valentina Trimarco, Edoardo Scomazzon

Int J Cancer· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic and Predictive Effect of IGHV Mutational Status and Load in Chronic Lymphocytic Leukemia: Focus on FCR and BR Treatments.
Andrea Visentin, Monica Facco, Carmela Gurrieri, Elisa Pagnin, Veronica Martini, Edoardo Scomazzon

Clin Lymphoma Myeloma Leuk· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The combination of complex karyotype subtypes and IGHV mutational status identifies new prognostic and predictive groups in chronic lymphocytic leukaemia.
Andrea Visentin, Laura Bonaldi, Gian Matteo Rigolin, Francesca Romana Mauro, Annalisa Martines, Edoardo Scomazzon

Br J Cancer· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BCR kinase inhibitors, idelalisib and ibrutinib, are active and effective in Richter syndrome.
Andrea Visentin, Silvia Imbergamo, Edoardo Scomazzon, Stefano Pravato, Federica Frezzato

Br J Haematol· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dabigatran in ibrutinib-treated patients with atrial fibrillation and lymphoproliferative diseases: Experience of 4 cases.
Andrea Visentin, Elena Campello, Edoardo Scomazzon, Luca Spiezia, Silvia Imbergamo

Hematol Oncol· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bendamustine plus rituximab is an effective first-line treatment in hairy cell leukemia variant: a report of three cases.
Andrea Visentin, Silvia Imbergamo, Federica Frezzato, Marco Pizzi, Roberta Bertorelle, Edoardo Scomazzon

Oncotarget· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cortactin, a Lyn substrate, is a checkpoint molecule at the intersection of BCR and CXCR4 signalling pathway in chronic lymphocytic leukaemia cells.
Veronica Martini, Cristina Gattazzo, Federica Frezzato, Valentina Trimarco, Marco Pizzi, Edoardo Scomazzon

Br J Haematol· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Major infections, secondary cancers and autoimmune diseases occur in different clinical subsets of chronic lymphocytic leukaemia patients.
Andrea Visentin, Silvia Imbergamo, Carmela Gurrieri, Federica Frezzato, Valentina Trimarco, Edoardo Scomazzon

Eur J Cancer· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis